SC 13D Filing

Company

Sarepta Therapeutics, Inc.

Filed

February 9, 2009

Accession Number

0000935836-09-000115

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →